ArticleGenetics in medicine open2025
Successes of an innovative population-based carrier screening program for 4 prevalent recessive hereditary diseases in a population with a founder effect in Quebec, Canada.
Article in Genetics in medicine open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Developing a Replicable Cardiogenetic Care Model: Insights from the Saguenay-Lac-Saint-Jean Founder Population.Journal of community genetics · 2026Article
- Rare diseases load through the study of a regional population.PLoS genetics · 2025Article
- HeterozygousFrontiers in physiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The Saguenay-Lac-Saint-Jean, Haute-Côte-Nord, and Charlevoix regions in Canada have a high prevalence of 4 autosomal recessive diseases with high morbidity and/or reduced life expectancy. As a result, a carrier screening program (CSP) was developed in 2010 and has been ongoing since. The program's purpose is to provide information and carrier screening for individuals having a higher probability to have an affected child to allow for informed decision making regarding reproductive choices. This publication provides an overview of the CSP, shares its results, and discusses the growing needs for expanding genetic testing and counseling. Methods: In 2018, the CSP transitioned from a regional to a provincially available program, supported by an innovative home self-sampling kit that can be requested online and returned by mail for analysis. For the purpose of this study, CSP data from 2010 to 2022 were extracted and analyzed. Results: The CSP has shown high acceptability. In total, 20,604 participants have been tested, identifying 3578 carriers of at least 1 condition who received genetic counseling. Carrier couples for the same condition ( Conclusion: The relatively inexpensive method could be applied to other populations with a high prevalence of certain autosomal recessive diseases. Given the program's results, we must consider adding the screening of other prevalent recessive conditions to the CSP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.